The Next "Botox" is Almost Here....

Xeomin (pronounced "Zee-o-men") has just been FDA-approved for use here in the States.  Xeomin is a new botulinum toxin from Merz, the company that makes Radiesse (a collagen-stimulator, wrinkle filler) and Asclara (for spider veins).

We don't know exactly how Xeomin will stack up against Botox and Dysport, but we do know that Xeomin is supposed to be a "purer" form of the botulinum toxin protein, and we know it doesn't have to be refrigerated, so it has a longer shelf-life.  We don't yet know if it will last longer than Botox or Dysport, or how it will work for areas other than the "11s" between the brows, which is presently the only area it's FDA-approved to treat.  And we don't yet know about it's cost.



As with many products, Europe has been using Xeomin for awhile now, even though it just became available here in the States.  In Europe, it's called Bocouture....which brings me to the issue of names for these wrinkle-reducers.


Why are all the names so unappealing??  "Botox" sounds like a poison. "Dysport" sounds dys-functional.  Xeomin, well, I had to figure out how to pronounce it!  Europe got the good name for Dysport (it's Reloxin over there", and they got the good name for Xeomin (Bocouture).  Not sure why we're getting all the bad names over here.

What do you think--will you try Xeomin as soon as it's available, or will you wait until it's more "tried and true" here?